Notice Regarding Change in Representative Directors[Teijin] (PDF: 278.6 KB)

(Translation) December 23, 2021

To whom it may concern

Company: Teijin Limited

Stock code: 3401 (First Section, Tokyo Stock Exchange)

Representative: Jun Suzuki, President and CEO

Contact: Tomoko Torii, General Manager,

Investor Relations Department

Tel: [phone]

Notice Regarding Change in Representative Directors

Teijin Limited (the "Company") hereby announces a change in its Representative Directors with the resolution of the Board of Directors Meeting held today, as detailed below:

1. Details of change

Name	Current Title	New Title
Jun Suzuki	President and CEO,	Chairman of Teijin Limited,
	Representative Director of the	Member of the Board
	Board
Akimoto Uchikawa	Executive Officer,	President and CEO,
	Member of the Board	Representative Director of
		the Board

2. Name and career summary of the newly appointed representative director

Name:	Akimoto Uchikawa
Date of birth:	January 18, 1966

Number of shares owned: 12,024 shares (as of September 30, 2021)

Career summary, position and responsibilities at the Company:

March 1990	Joined Teijin Limited
June 1990	Fiber and Textile Research Institute
December 1994	On loan to MAEDAKOSEN CO., LTD.
March 1998	Functional Fiber Technology and Development Division,
	Fiber Business Unit
September 1998	Industrial Materials Development Center, Functional Fiber
	Technology and Development Division
July 2003	Teijin Twaron B.V. (The Netherlands)
July 2008	Manager of Aramid Product Development Section, Teijin
	Techno Products Limited
October 2012	General Manager of Product Development Department,
	Manager of Reinforcing Material Development Section,
	High-Performance Fibers Business Unit
March 2013	General Manager of Product Development Department,
	General Manager of Osaka Research Center, High-
	Performance Fibers Business Unit
October 2013	General Manager of Solution Development Department,
	General Manager of Osaka Research Center, High-
	Performance Fibers Business Unit
December 2014	General Manager, Production, Research and
	Development Division, High-Performance Fibers Business
	Unit
January 2017	Deputy General Manager, High-Performance Fibers
	Business Unit (Production, Research and Development)
April 2017	Teijin Group Corporate Officer
	Management Coordinator for the President, Material

	Business of Teijin Group
	Assistant to General Manager, Fibers and Products
	Converting Business Group (for Technology, Production,
	Restructuring Initiatives)
April 2020	Teijin Group Corporate Officer
	General Manager, Composites Business Unit
April 2021	Teijin Group Executive Officer
	President, Material Business of Teijin Group
June 2021	Executive Officer, Member of the Board (incumbent)
	President, Material Business of Teijin Group (incumbent)

3. Scheduled date of appointment April 1, 2022

(Attachment) News release of Change in President and CEO

- End -

For Immediate Release

Teijin Board Elects Akimoto Uchikawa as New President and CEO

- Jun Suzuki to Become Chairman -

TOKYO, JAPAN, December 23, 2021 ---Teijin Limitedannounced today that its board of directors has elected Akimoto Uchikawa, currently Executive Officer, Member of the Board, as its next President and Chief Executive Officer (CEO). Uchikawa will assume his new role on April 1, 2022.

Jun Suzuki, the current President and CEO of the company, will assume the post of Chairman of Teijin Limited, on the same day.

Uchikawa has concurrently served as President, Material Business of Teijin Group.

The executive appointments were recommended by Teijin's Advisory Board. The Advisory Board, which includes Independent Outside Directors and Advisors both from Japan and overseas, was established in July 1999 to strengthen group-wide corporate governance. The Nomination Committee, reporting to the Advisory Board and chaired by an Independent Outside Director, is responsible for evaluating business performance of CEO and selecting its best candidate to succeed. The decision of selecting the new President and CEO was also discussed and agreed by the Nomination Committee.

About the Teijin Group

Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the fields of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Originally established as Japan's first rayon manufacturer in 1918, Teijin has evolved into a unique enterprise encompassing three core business domains: high-performance materials including aramid, carbon fibers and composites, and also resin and plastic processing, films, polyester fibers and products converting; healthcare including pharmaceuticals and home healthcare equipment for bone/joint, respiratory and cardiovascular/metabolic diseases, nursing care and pre-symptomatic healthcare; and IT including B2B solutions for medical, corporate and public systems as well as packaged software and B2C online services for digital entertainment. Deeply committed to its stakeholders, as expressed in the brand statement "Human Chemistry, Human Solutions," Teijin aims to be a company that supports the society of the future. The group comprises more than 170 companies and employs some 20,000 people across 20 countries worldwide. Teijin posted consolidated sales of JPY 836.5 billion (USD 7.7 billion) and total assets of JPY 1,036.4 billion (USD 9.5 billion) in the fiscal year that ended on March 31, 2021.

Please visit www.teijin.com.

Press Contact

Corporate Communications

Teijin Limited

[phone] [e-mail]

Attachment 1

Jun Suzuki

Date of birth: February 19, 1958 (age: 63)

Titles:President and CEO, Representative Director of the Board, Teijin Limited

Birthplace:

Tokyo, Japan

Education: Graduated from Faculty of Science, University of Tokyo, March 1981 Earned Master of Science from Department of Zoology, Graduate

School of Science, University of Tokyo, March 1983

Awarded Doctor of Philosophy in Medical Science from Graduate School of Medicine, Osaka University, February 1996

Career:

April 1983 Joined Teijin Limited

October 1983 Biotechnology Research Department, Teijin Central Research Institute

June 1994 Teijin Biomedical Laboratory in England

August 1997 Pharmaceutical Discovery Research LaboratoriesⅡ

April 2002 General Manager of Bio-medical Evaluation Research Department, Pharmaceutical Discovery Research Laboratories, Teijin Limited

October 2003 General Manager of Pharmaceutical Planning Department, Teijin Pharma Limited

April 2006 General Manager of Licensing & Business Development Department, Teijin Pharma Limited

April 2007 General Manager of Pharmaceutical Business Planning Department, Teijin Pharma Limited

April 2008 General Manager of Pharmaceutical Development Research Laboratories, Teijin Pharma Limited

April 2009 General Manager of Pharmaceutical & Healthcare Business Planning Department, Teijin Pharma Limited

April 2011 Teijin Group Chief Representative in Europe President of Teijin Holdings Netherlands B.V.

April 2012 Teijin Group Corporate Officer

Chief Marketing Officer and Director BRICs Business

April 2013 Teijin Group Executive Officer

General Manager of Advanced Fibers & Composites Business Group General Manager of Carbon Fibers & Composites Business Unit President and Representative Director of Toho Tenax Co., Ltd.

June 2013 Member of the Board, Executive Officer.

April 2014 President and CEO, Representative Director of the Board, Teijin Limited (incumbent)

April 2022 To be appointed Chairman of Teijin Limited, Member of the Board